Vaccines
October is RSV Awareness Month
RSV is a respiratory virus that affects the lungs and breathing passages. Each year, approximately 177,000 adults 65 years and older are hospitalized in the US due to RSV. Our patient advocate, Irene, tells her story about what it was like having RSV.
Investors
We announced our quarter 1 2024 results on Wednesday, May 1st.
Press releases
- ViiV Healthcare shows more than 99% effectiveness in real-world studies for Apretude (cabotegravir long-acting), the only approved long-acting HIV PrEP, in data presented at IDWeek 2024
- Gepotidacin accepted for priority review by US FDA for treatment of uncomplicated urinary tract infections in female adults and adolescents
- GSK and ViiV Healthcare to showcase advances across industry-leading infectious disease portfolio at IDWeek 2024
Choose your path
By bringing outstanding people together in an inclusive environment to do work that matters, we can impact the world’s health.
GSK Global links
Visit our Global site for additional features